JAZZ Dividend History & Analysis | N/A Yield
JAZZ has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| SIGA | 593 M | 7.12% | 11.4% |
| PFE | 138,102 M | 8.70% | 7.22% |
| OGN | 1,755 M | 9.40% | 2.20% |
| PRGO | 2,853 M | 7.59% | 2.93% |
| BMY | 93,773 M | 5.34% | 4.70% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| RPRX | 21,892 M | 29.4% | 100% |
| ZTS | 63,858 M | 21.2% | 100% |
| LLY | 772,276 M | 15.1% | 99.5% |
| SIGA | 593 M | 15.5% | 98.8% |
| RDY | 11,250 M | 28.0% | 87.3% |
Similar Stocks with Attractive Dividends - Compare JAZZ Dividends with its Peer-Group
7.12% Yield
2.70% Yield
3.84% Yield
3.48% Yield
4.60% Yield
3.43% Yield
JAZZ Dividend History: as of November 2025
No dividends paid yet.JAZZ Dividend FAQ
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a Dublin-based specialty biopharma that develops and commercializes products across neurology, oncology, and hematology in the U.S., Europe, and other markets. Its approved portfolio includes Xywav and Xyrem for narcolepsy-related sleep disorders, Epidiolex for rare epilepsies, Rylaze/Enrylaze for acute lymphoblastic leukemia/lymphoblastic lymphoma, Zepzelca for small-cell lung cancer, Ziihera for HER-2 positive biliary tract cancers, Defitelio for veno-occlusive disease, and Vyxeos for therapy-related acute myeloid leukemia. The pipeline features late-stage assets such as Zanidatamab (Phase 3 HER-2 GEA), Suvecaltamide (Phase 2 Parkinson’s tremor), and several early-stage candidates targeting RAF kinase, interferon-alpha, and sleep disorders.
What is the Dividend Yield of JAZZ?
As of November 2025, JAZZ`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 137.22.Does JAZZ pay a dividend?
As of November 2025 JAZZ does not pay a dividend.How often does JAZZ pay dividends?
Over the last 12 months, JAZZ has issued dividend payments.Will JAZZ pay dividends in 2025?
The next Ex-Dividend date for Jazz Pharmaceuticals (JAZZ) is currently unknown.What is the next Ex-Dividend Date for JAZZ?
The next Ex-Dividend date for Jazz Pharmaceuticals (JAZZ) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of JAZZ?
JAZZ's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of JAZZ?
JAZZ's 5-Year Yield on Cost is -%. If you bought JAZZ's shares at 146.18 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of JAZZ?
JAZZ Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does JAZZ have a good Dividend Yield?
JAZZ`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of JAZZ?
The Dividend Payout Ratio of JAZZ is unknown.What is the Dividend Rating of JAZZ?
JAZZ`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-20 04:39